Sun.Dec 04, 2022

article thumbnail

Elon Musk’s Neuralink brain interface chip set for human trials

Pharma Phorum

Clinical trials of a wireless brain chip developed by Elon Muck’s Neuralink company will be tested in human volunteers within the next six months – and Musk himself says he intends to have one implanted for a future demo event.

FDA 90
article thumbnail

Humira biosimilars set the stage for long-awaited 2023 US launches

Pharmaceutical Technology

Starting in January, multiple biosimilars of AbbVie’s blockbuster drug Humira are set to flood the US pharmaceutical market.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Addressing leadership barriers for women in tech and pharma

Pharma Phorum

Contrary to Big Tech, historically the pharmaceutical industry has had a good reputation for being a female-positive industry. However, both industries share a common problem: failure to provide women with C-suite opportunities.

86
article thumbnail

Expert Discusses PD-1 Inhibitors as Treatment of NSCLC

Pharmacy Times

Scott Soefje, director of Pharmacy Cancer Care and assistant professor of Pharmacy at Mayo Clinic, discusses PD-1 inhibitors and its use in non–small cell lung cancer.

article thumbnail

Sanofi, Amgen acknowledge Horizon interest as J&J steps back

Pharma Phorum

Amgen and Sanofi have said they may make cash-only offers for Horizon Therapeutics, which confirmed it was in talks with potential buyers last week, but Johnson & Johnson has ruled itself out of the running.

79
article thumbnail

Amgen to push latecomer obesity drug into midstage testing

Pharma Phorum

Amgen is lagging behind rivals like Novo Nordisk and Eli Lilly with its new-generation therapy for obesity, but is sufficiently encouraged by early-stage clinical data to kick off a phase 2 programme for the drug next year.

FDA 75